I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
- To evaluate Blood Pressure (BP) reduction to the targeted values (BP ≤ 140/90 mm Hg in
non-diabetic patients, and ≤ 130/80 mm Hg in diabetic patients).
- To emphasize and to evaluate the benefit of Irbesartan in the reduction of left
ventricular mass index in hypertensive patients with left ventricular hypertrophy.
- To demonstrate safety of Irbesartan in this population.